David Pierce an Insider in Boston Scientific (BSX) Unloaded 5,000 Shares; Mayo Investment Advisers Has Decreased Domtar Com New (UFS) Holding By $1.38 Million

Domtar Corporation (NYSE:UFS) Logo

Mayo Investment Advisers Llc decreased Domtar Corp Com New (UFS) stake by 33.07% reported in 2017Q4 SEC filing. Mayo Investment Advisers Llc sold 28,150 shares as Domtar Corp Com New (UFS)’s stock declined 14.06%. The Mayo Investment Advisers Llc holds 56,985 shares with $2.82 million value, down from 85,135 last quarter. Domtar Corp Com New now has $2.63 billion valuation. The stock increased 2.04% or $0.84 during the last trading session, reaching $42.02. About 804,452 shares traded or 9.40% up from the average. Domtar Corporation (NYSE:UFS) has risen 15.04% since April 3, 2017 and is uptrending. It has outperformed by 3.49% the S&P500.

Since February 28, 2018, it had 0 insider purchases, and 5 selling transactions for $5.63 million activity. 15,000 shares were sold by LOULOU PATRICK, worth $684,150. Buron Daniel had sold 16,853 shares worth $775,069 on Friday, March 16. Williams John David also sold $3.10M worth of Domtar Corporation (NYSE:UFS) shares. Fagan Michael also sold $1.06 million worth of Domtar Corporation (NYSE:UFS) shares.

Investors sentiment increased to 1.51 in 2017 Q4. Its up 0.34, from 1.17 in 2017Q3. It is positive, as 15 investors sold UFS shares while 79 reduced holdings. 53 funds opened positions while 89 raised stakes. 56.70 million shares or 1.73% more from 55.74 million shares in 2017Q3 were reported. Meritage Port stated it has 0.31% in Domtar Corporation (NYSE:UFS). 140 were reported by Community Financial Bank Na. Arrowstreet Limited Partnership stated it has 110,300 shares or 0.01% of all its holdings. Gru One Trading LP has 1,340 shares. American Grp Incorporated holds 129,709 shares or 0.02% of its portfolio. Letko Brosseau And Assocs holds 0.01% or 16,975 shares. Blackrock Incorporated holds 9.59M shares. Jefferies Grp Limited Liability Company reported 257,323 shares. Bluecrest Capital Ltd owns 16,109 shares for 0.02% of their portfolio. Aqr Cap Management Ltd Limited Liability Company holds 0% of its portfolio in Domtar Corporation (NYSE:UFS) for 19,020 shares. Hl Ltd Liability Corporation invested in 9,010 shares or 0.01% of the stock. Wells Fargo Comm Mn holds 0% of its portfolio in Domtar Corporation (NYSE:UFS) for 279,785 shares. 86,070 were reported by Twin. Teacher Retirement Of Texas accumulated 0.01% or 21,494 shares. Proshare Advisors Ltd Limited Liability Company reported 0% in Domtar Corporation (NYSE:UFS).

Among 15 analysts covering Domtar Corp. (NYSE:UFS), 4 have Buy rating, 3 Sell and 8 Hold. Therefore 27% are positive. Domtar Corp. had 44 analyst reports since October 15, 2015 according to SRatingsIntel. The stock has “Sector Perform” rating by National Bank Canada on Friday, April 15. On Friday, February 9 the stock rating was upgraded by Vertical Research to “Buy”. Citigroup downgraded it to “Sell” rating and $40.0 target in Thursday, October 5 report. KeyBanc Capital Markets maintained Domtar Corporation (NYSE:UFS) rating on Sunday, July 30. KeyBanc Capital Markets has “Sell” rating and $3300 target. The rating was maintained by Citigroup with “Neutral” on Tuesday, August 2. The firm has “Buy” rating given on Thursday, October 19 by RBC Capital Markets. The rating was downgraded by DA Davidson to “Underperform” on Friday, July 8. RBC Capital Markets downgraded the stock to “Hold” rating in Friday, January 12 report. The firm has “Hold” rating given on Friday, May 26 by BMO Capital Markets. The firm has “Hold” rating by Stephens given on Wednesday, January 24.

Analysts await Domtar Corporation (NYSE:UFS) to report earnings on April, 26. They expect $0.70 earnings per share, up 118.75% or $0.38 from last year’s $0.32 per share. UFS’s profit will be $43.88M for 15.01 P/E if the $0.70 EPS becomes a reality. After $0.64 actual earnings per share reported by Domtar Corporation for the previous quarter, Wall Street now forecasts 9.37% EPS growth.

Investors sentiment increased to 1.34 in 2017 Q4. Its up 0.30, from 1.04 in 2017Q3. It is positive, as 36 investors sold Boston Scientific Corporation shares while 158 reduced holdings. 86 funds opened positions while 174 raised stakes. 1.18 billion shares or 2.38% less from 1.21 billion shares in 2017Q3 were reported. Private Wealth Prns Lc reported 1.31% of its portfolio in Boston Scientific Corporation (NYSE:BSX). Quantitative Systematic Strategies Lc reported 0.63% stake. Northern Corp has 0.1% invested in Boston Scientific Corporation (NYSE:BSX) for 15.16 million shares. Parametric Portfolio Associate Limited Liability Corporation invested in 2.88 million shares or 0.07% of the stock. Pathstone Family Office Limited Liability Com holds 0.14% or 10,000 shares. Rmb Capital Limited Liability accumulated 0.01% or 13,843 shares. Sector Gamma As has invested 7.09% in Boston Scientific Corporation (NYSE:BSX). Nj State Employees Deferred Compensation Plan holds 0.17% of its portfolio in Boston Scientific Corporation (NYSE:BSX) for 40,000 shares. Connecticut-based Virtus Investment Advisers Inc has invested 0.07% in Boston Scientific Corporation (NYSE:BSX). Comerica State Bank holds 365,319 shares or 0.07% of its portfolio. Drw Secs Ltd Liability Corporation holds 0.05% or 19,248 shares in its portfolio. Ahl Prtn Ltd Liability Partnership has invested 0.07% in Boston Scientific Corporation (NYSE:BSX). Swiss Commercial Bank reported 5.69 million shares or 0.15% of all its holdings. Caxton Ltd Partnership invested in 44,975 shares or 0.05% of the stock. State Of New Jersey Common Pension Fund D accumulated 0.05% or 490,000 shares.

Analysts await Boston Scientific Corporation (NYSE:BSX) to report earnings on April, 26. They expect $0.31 EPS, up 6.90% or $0.02 from last year’s $0.29 per share. BSX’s profit will be $426.22M for 22.15 P/E if the $0.31 EPS becomes a reality. After $0.34 actual EPS reported by Boston Scientific Corporation for the previous quarter, Wall Street now forecasts -8.82% negative EPS growth.

David Pierce, EVP – Pres MedSurg of Boston Scientific Corp is the insider, OctaFinance want to report transactions for. Mr. David submitted a legal form with the U.S. Security and Exchange Commission revealing a deal for 5,000 shares of the Massachusetts-based company, the one he is an insider in. At the time of the dealing, the average stock price of Boston Scientific Corp was $27.2, making the insider trade worth $136,125 US Dollars. He also unloaded 8,800 shares worth $238,558 USD in the last month. And, It’s sure David’s sell isn’t going to remain unseen as he currently is having 24,201 shares – ( 0.00% of Boston Scientific Corp’s Market Cap ).

The stock increased 2.31% or $0.62 during the last trading session, reaching $27.46. About 9.05 million shares traded or 10.75% up from the average. Boston Scientific Corporation (NYSE:BSX) has risen 9.97% since April 3, 2017 and is uptrending. It has underperformed by 1.58% the S&P500.

Boston Scientific Corporation develops, makes, and markets medical devices for use in various interventional medical specialties worldwide. The company has market cap of $37.76 billion. It operates through three divisions: Cardiovascular, Rhythm Management, and MedSurg. It has a 361.32 P/E ratio. The firm offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; other coronary therapy products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as certain peripheral vessels; and structural heart therapy systems.

Boston Scientific Corporation (NYSE:BSX) Institutional Positions Chart